Porous poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects

Tissue Engineering

Volumn 12, Issue 4, 2006, Pages 789-800

  Ruhé, P Quinten ^a   Hedberg Dirk, Elizabeth L ^b   Padron, Nestor Torio ^b   Spauwen, Paul H M ^a   Jansen, John A ^a   Mikos, Antonios G ^b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b Rice University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIC MATERIALS; HISTOLOGY; POROSITY; POROUS MATERIALS;

BONE RESPONSE; BONE TISSUE ENGINEERING; MICROPARTICLES; MINERALIZATION;

BONE CEMENT;

BONE CEMENT; CALCIUM PHOSPHATE; CARBON DIOXIDE; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE GROWTH; BONE MINERALIZATION; BONE REGENERATION; BONE REMODELING; CONTROLLED STUDY; HYDROLYSIS; MALE; NONHUMAN; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; RAT; SKULL DEFECT; TISSUE ENGINEERING;

ABSORBABLE IMPLANTS; ANIMALS; BONE CEMENTS; BONE SUBSTITUTES; CALCIUM PHOSPHATES; IMPLANTS, EXPERIMENTAL; LACTIC ACID; MALE; NANOSTRUCTURES; PARIETAL BONE; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; POROSITY; RATS; RATS, WISTAR; TISSUE ENGINEERING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33646547587     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.12.789     Document Type: Article

References (36)

1. Friedman, C.D., Costantino, P.D., Takagi, S., and Chow, L.C. BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed. Mater. Res. 43, 428, 1998.
2. Ladd, A.L., and Pliam, N.B. Use of bone-graft substitutes in distal radius fractures. J. Am. Acad. Orthop. Surg. 7, 279, 1999.
3. Larsson, S., and Bauer, T.W. Use of injectable calcium phosphate cement for fracture fixation: a review. Clin. Orthop. 395, 23, 2002.
4. Brown, W.E., and Chow, L.C. Dental restorative cement pastes. US. patent 4,518,430, 1985.
5. LeGeros, R.Z. Calcium Phosphates in Oral Biology and Medicine. Monographs in Oral Science, Vol. 15. Basel: Karger, 1991.
6. Schmitz, J.P., Hollinger, J.O., and Milam, S.B. Reconstruction of bone using calcium phosphate bone cements: a critical review. J. Oral Maxillofac. Surg. 57, 1122, 1999.
7. Comuzzi, L., Ooms, E., and Jansen, J.A. Injectable calcium phosphate cement as a filler for bone defects around oral implants: an experimental study in goats. Clin. Oral Implant. Res. 13, 304, 2002.
8. del Real, RP., Ooms, E., Wolke, J., Vallet-Regi, M., and Jansen, J.A. In vivo bone response to porous calcium phosphate cement. J. Biomed. Mater. Res. 65A, 30, 2003.
9. Kroese-Deutman, H.C., Ruhe, P.Q., Spauwen, P.H., and Jansen, J.A. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits. Biomaterials 26, 1131, 2005.
10. Ooms, E.M., Wolke, J.G., van der Waerden, J.P., and Jansen, J.A. Trabecular bone response to injectable calcium phosphate (Ca-P) cement. J. Biomed. Mater. Res. 61, 9, 2002.
11. Ooms, E.M., Wolke, J.G., van der Waerden, J.P., and Jansen, J.A. Use of injectable calcium-phosphate cement for the fixation of titanium implants: an experimental study in goats. J. Biomed. Mater. Res. 66B, 447, 2003.
12. Ooms, E.M., Egglezos, E.A., Wolke, J.G., and Jansen, J.A. Soft-tissue response to injectable calcium phosphate cements. Biomaterials 24, 749, 2003.
13. Ooms, E.M., Wolke, J.G., van de Heuvel, M.T., Jeschke, B., and Jansen, J.A. Histological evaluation of the bone response to calcium phosphate cement implanted in cortical bone. Biomaterials 24, 989, 2003.
14. Ruhe, P.Q., Kroese-Deutman, H.C., Wolke, J.G., Spauwen, P.H., and Jansen, J.A. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits. Biomaterials 25, 2123, 2004.
15. Chow, L.C. Calcium Phosphate Cements. Monographs in Oral Science, Vol. 18. Basel: Karger, 2001. pp. 148-163.
16. Clokie, C.M., Moghadam, H., Jackson, M.T., and Sandor, G.K. Closure of critical sized defects with allogenic and alloplastic bone substitutes. J. Craniofac. Surg. 13, 111, 2002.
17. Schliephake, H., Gruber, R., Dard, M., Wenz, R., and Scholz, S. Repair of calvarial defects in rats by prefabricated hydroxyapatite cement implants. J. Biomed. Mater. Res. 69A, 382, 2004.
18. Lu, L., Stamatas, G.N., and Mikos, A.G. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J. Biomed. Mater. Res. 50, 440, 2000.
19. Hedberg, E.L., Tang, A., Crowther, R.S., Carney, D.H., and Mikos, A.G. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites. J. Control Release 84, 137, 2002.
20. Ruhe, P.Q., Hedberg, E.L., Padron, N.T., Spauwen, P.H., Jansen, J.A., and Mikos, A.G. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. J. Bone Joint Surg. 85A, suppl 3, 75, 2003.
21. Shive, M.S., and Anderson, J.M. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28, 5, 1997.
22. del Real, R.P., Wolke, J.G., Vallet-Regi, M., and Jansen, J.A. A new method to produce macropores in calcium phosphate cements. Biomaterials 23, 3673, 2002.
23. Cleek, R.L., Rege, A.A., Denner, L.A., Eskin, S.G., and Mikos, A.G. Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. J. Biomed. Mater. Res. 35, 525, 1997.
24. Peter, S.J., Lu, L., Kim, D.J., Stamatas, G.N., Miller, M.J., Yaszemski, M.J., and Mikos, A.G. Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J. Biomed. Mater. Res. 50, 452, 2000.
25. van der Lubbe, H.B., Klein, C.P., and de Groot, K. A simple method for preparing thin (10 microM) histological sections of undecalcified plastic embedded bone with implants. Stain Technol. 63, 171, 1988.
26. Squires, G.L. Further topics in statistical theory; functions of several variables. In: Squires, G.L., ed., Practical physics, 3rd ed. Cambridge: Cambridge University Press, 1985, pp. 33-46.
27. Sikavitsas, V.I., van den, D.J., Bancroft, G.N., Jansen, J.A., and Mikos, A.G. Influence of the in vitro culture period on the in vivo performance of cell/titanium bone tissue-engineered constructs using a rat cranial critical size defect model. J. Biomed. Mater. Res. 67A, 944, 2003.
28. Blum, J.S., Barry, M.A., Mikos, A.G., and Jansen, J.A. In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model. Hum. Gene Ther. 14, 1689, 2003.
29. Kuboki, Y., Jin, Q., and Takita, H. Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis. J. Bone Joint Surg. 83A, suppl 1, 105, 2001.
30. Tsuruga, E., Takita, H., Itoh, H., Wakisaka, Y., and Kuboki, Y. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J. Biochem. (Tokyo) 121, 317, 1997.
31. LeGeros, R.Z. Properties of osteoconductive biomaterials: calcium phosphates. Clin. Orthop. 395, 81, 2002.
32. Ripamonti, U. Smart biomaterials with intrinsic osteoinductivity: geometric control of bone differentiation. In: Davies J.E., ed., Bone Engineering. Toronto: EM Squared, 2000, pp. 215-222.
33. Ripamonti, U., and Crooks, J.a.K.A.N. Sintered porous hydroxyapatites with intrinsic osteoinductive activity: geometric induction of bone formation. S. Afr. J. Sci. 95, 335, 1999.
34. Yuan, H., Kurashina, K., de Bruijn, J.D., Li, Y., de Groot, K., and Zhang, X. A preliminary study on osteoinduction of two kinds of calcium phosphate ceramics. Biomaterials 20, 1799, 1999.
35. Simon, G.G., Khatri, C.A., Wight, S.A., and Wang, F.W. Preliminary report on the biocompatibility of a moldable, resorbable, composite bone graft consisting of calcium phosphate cement and poly(lactide-co-glycolide) microspheres. J. Orthop. Res. 20, 473, 2002.
36. Ruhe, P.Q., Hedberg, E.L., Padron, N.T., Spauwen, P.H., Jansen, J.A., and Mikos, A.G. Biocompatibility and degradation of poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composites. J. Biomed. Mater. Res. Part A. 74A, 533, 2005.